Form 8-K ORTHOPEDIATRICS CORP For: Sep 12

Go back to Form 8-K ORTHOPEDIATRICS CORP For: Sep 12

Needham Reiterates Buy Rating on OrthoPediatrics Corp. (KIDS)

September 13, 2024 5:15 AM EDT

Needham analyst Mike Matson reiterated a Buy rating and $42.00 price target on OrthoPediatrics Corp. (NASDAQ: KIDS).

The analyst comments "At KIDS' 9/12/24 investor day, management provided updates on growth strategies for Scoliosis and Trauma & Deformity (T&D), announced the launch of the Enabling... More

OrthoPediatrics Corp. (KIDS) PT Raised to $34 at Truist Securities

September 13, 2024 5:13 AM EDT

Truist Securities analyst Kaila Krum raised the price target on OrthoPediatrics Corp. (NASDAQ: KIDS) to $34.00 (from $30.00) while maintaining a Hold rating.

The analyst comments "KIDS' I-Day emphasized a diversifying set of growth drivers---new prod launches, addt'l target markets, and a scaling sales... More